04:56:15 EST Wed 01 Dec 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Aurora Cannabis Inc (2)
Symbol ACB
Shares Issued 198,068,923
Close 2021-08-25 C$ 8.94
Recent Sedar Documents

Aurora Cannabis, Ethypharm ship pot for French pilot

2021-08-25 09:42 ET - News Release

Mr. Miguel Martin reports

AURORA CANNABIS MARKS SUCCESSFUL INAUGURAL FULFILLMENT FOR FRENCH PILOT PROGRAM

Aurora Germany GmbH, a subsidiary of Aurora Cannabis Inc., and Ethypharm have successfully delivered their initial shipment of cannabis to the French medical cannabis pilot program, set to begin serving patients in the coming weeks. Aurora and Ethypharm were selected by the National Agency for the Safety of Medicines and Health Products (ANSM) to supply the entire medical cannabis dried flower range (three lots of the tender) to French patients during the pilot program.

"The first prescriptions of dried medical cannabis as part of the French pilot program are a significant step toward providing access to patients and will support the destigmatization of medical cannabis in France," said Miguel Martin, chief executive officer of Aurora Cannabis. "This accomplishment is another example of Aurora's leadership in global cannabis, with a proven track record of supporting the advancement of international medical cannabis markets alongside government bodies. By demonstrating a deep commitment to compliance and focus on product quality, we won three of the nine available tenders. If successful, this pilot program could lead to one of the largest regulated medical cannabis markets in Europe."

"Combining our pharmaceutical skills is, in our view, the right approach to build trust and confidence in medical cannabis for the long term in France," declared Jean Monin, chief commercial operations officer of Ethypharm. "We want to be a driving force to support patients suffering from chronic pain when there is no other therapeutic option than medical cannabis. With our deep expertise in disorders of the central nervous system and an expertise in highly regulated medicines, we are well prepared to collaborate with the health authorities and physicians. If positive, Ethypharm will, as a pharmaceutical company, ensure distribution and patient access to new therapeutic cannabis options."

Aurora Nordic, the company's European Union good manufacturing practice (EU GMP) production facility certified by the Danish Health Authority in Odense, Denmark, is committed to providing sufficient and consistent supply to patients and health care professionals for the pilot program. There are three types of high-quality pharmaceutical-grade dried flower medical cannabis available in the pilot program: Aurora 20/1 XPE (high-THC (tetrahydrocannabinol) dried flower), Aurora 8/8 XPE (THC/CBD (cannabidiol) balanced dried flower) and Aurora 1/12 XPE (high-CBD dried flower). Dried flower is administered with a vaporizer by Storz & Bickel, a reputable medical device tested and used by patients across Europe, recently selected by the ANSM. Up to 3,000 patients will benefit from the two-year trial led by the ANSM.

Aurora and Ethypharm signed an agreement to serve the French pilot program in October, 2020, leveraging both parties' expertise. Under the terms of the exclusive agreement, Aurora supplies medical cannabis sourced from the company's largest greenhouse production facility on European soil, Aurora Nordic, as well as EU GMP manufacturing and logistics support. Ethypharm's French subsidiary, Laboratoires Ethypharm, is responsible for pharmaceutical distribution in France.

About Aurora Cannabis Inc.

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Pedanios, Whistler and Reliva CBD. Providing customers with innovative, high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched.

Aurora's common shares trade on the Toronto Stock Exchange and the Nasdaq Stock Market under the symbol ACB and the company is a constituent of the S&P/TSX Composite Index.

We seek Safe Harbor.

© 2021 Canjex Publishing Ltd. All rights reserved.